bronchopneumonia 英 /,brɒŋkə(ʊ)njuː'məʊnɪə/ 美 /,brɑŋkonjʊ'monjə/
释 义 n. [内科] 支气管肺炎
同根词 adj. bronchial 支气管的；bronchitic 支气管炎的；bronchoscopic 支气管镜的
n. bronchodilator [内科][药] 支气管扩张剂；支气管扩张器
例 句 This abscessing bronchopneumonia has numerous areas of raised, lighter tan appearance which are the areas containing the extensive neutrophilic infiltrates. 脓肿化的支气管肺炎可见大量隆起的浅棕色病灶，病灶中有广泛的中性粒细胞浸润。
作者： Brand Jeffrey D.
Severe influenza (IAV) infection can develop into bronchopneumonia and edema, leading to acquired respiratory distress syndrome (ARDS) and pathophysiology. Underlying causes for pulmonary edema and aberrant fluid regulation largely remain unknown, particularly regarding the role of viral-mediated mechanisms. Multiple lines of evidence indicated ENaC and CFTR dysfunction during the acute infection period; however, only CFTR dysfunction persisted beyond the infection period. ENaC, CFTR, and Na, K-ATPase activities and protein levels were also reduced in virally infected human airway epithelial cells. Reduced ENaC and CFTR led to changes in airway surface liquid morphology of human tracheobronchial cultures and airways of IAV-infected mice. Pharmacologic correction of CFTR function ameliorated IAV-induced physiologic changes. These changes are consistent with mucous stasis and pulmonary edema; furthermore, they indicate that repurposing therapeutic interventions correcting CFTR dysfunction may be efficacious for treatment of IAV lung pathophysiology.